Ondansetron Hydrochloride Tablet, Film Coated
Product Images NDC 42708-059

2 FDA label images from Qpharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 42708-059). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ondansetron Str)

Chemical Structure (Ondansetron Str)
Chemical structure diagram of Ondansetron Hydrochloride, the active ingredient in this medication, showing its molecular composition and arrangement including the hydrochloride and dihydrate components.*
FDA Label Image

Label (42708 059 05 Label)

Label (42708 059 05 Label)
Label for Ondansetron Tablets USP 8 mg, film-coated oral tablets, containing 5 tablets. The label from MedStart features dosage instructions with blanks for personalized directions. Distributed by QPharma, Inc., and includes storage instructions to keep at controlled room temperature and tightly closed, out of reach of children. Sample not for sale.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.